Go Pro

Agilent Technologies (NYSE:A) Releases FY 2026 Earnings Guidance

Agilent Technologies logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Agilent raised its FY 2026 outlook, guiding for EPS of $6.18–$6.21 and revenue of approximately $7.5 billion, above analyst estimates of $6.06 EPS and $7.4 billion in revenue. Q4 EPS guidance was set at $1.71–$1.74.
  • The company’s latest quarter exceeded expectations, with EPS of $1.62 versus the $1.49 consensus and revenue of $1.88 billion versus $1.84 billion expected.
  • Analyst sentiment remains positive but mixed: Agilent has a consensus “Moderate Buy” rating and a $160.24 price target, while shares recently traded at $155.16, up 0.3%.
  • Five stocks we like better than Agilent Technologies.

Agilent Technologies (NYSE:A - Get Free Report) updated its FY 2026 earnings guidance on Wednesday. The company provided EPS guidance of 6.180-6.210 for the period, compared to the consensus estimate of 6.060. The company issued revenue guidance of $7.5 billion-$7.5 billion, compared to the consensus revenue estimate of $7.4 billion. Agilent Technologies also updated its Q4 2026 guidance to 1.710-1.740 EPS.

Analysts Set New Price Targets

A has been the subject of a number of recent analyst reports. Piper Sandler initiated coverage on Agilent Technologies in a research report on Thursday, June 11th. They issued a "neutral" rating and a $150.00 price objective for the company. HSBC lowered their target price on Agilent Technologies from $180.00 to $165.00 and set a "buy" rating on the stock in a report on Wednesday, June 3rd. Weiss Ratings upgraded shares of Agilent Technologies from a "hold (c-)" rating to a "hold (c)" rating in a research report on Tuesday, June 2nd. TD Cowen lifted their target price on Agilent Technologies from $147.00 to $155.00 and gave the company a "buy" rating in a research report on Thursday, May 28th. Finally, Jefferies Financial Group initiated coverage on shares of Agilent Technologies in a report on Thursday, July 9th. They issued a "hold" rating and a $135.00 price objective on the stock. Two analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $160.24.

Get Our Latest Stock Analysis on A

Agilent Technologies Stock Up 0.3%

Shares of A traded up $0.39 during mid-day trading on Wednesday, reaching $155.16. The company's stock had a trading volume of 3,131,622 shares, compared to its average volume of 2,234,282. The stock has a market cap of $43.82 billion, a PE ratio of 31.16, a price-to-earnings-growth ratio of 2.71 and a beta of 1.25. Agilent Technologies has a 12-month low of $108.35 and a 12-month high of $160.51. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. The company's 50 day moving average is $138.55 and its 200 day moving average is $126.47.

Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, topping the consensus estimate of $1.49 by $0.13. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.84 billion. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Equities analysts anticipate that Agilent Technologies will post 6.05 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the company. State of Wyoming purchased a new position in shares of Agilent Technologies during the second quarter valued at approximately $35,000. Transamerica Financial Advisors LLC increased its stake in Agilent Technologies by 180.8% during the fourth quarter. Transamerica Financial Advisors LLC now owns 337 shares of the medical research company's stock worth $46,000 after acquiring an additional 217 shares during the last quarter. Johnson Financial Group Inc. acquired a new stake in Agilent Technologies during the 3rd quarter worth approximately $49,000. DV Equities LLC purchased a new stake in Agilent Technologies during the fourth quarter worth approximately $54,000. Finally, Itau Unibanco Holding S.A. acquired a new stake in Agilent Technologies in the 4th quarter valued at $58,000.

Agilent Technologies Company Profile

(Get Free Report)

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

See Also

Earnings History and Estimates for Agilent Technologies (NYSE:A)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Agilent Technologies Right Now?

Before you consider Agilent Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.

While Agilent Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines